RDVT Stock Red Violet (RDVT, $73.05) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 10, 2026
at Tickeron.com
This is a Bearish indicator signaling RDVT's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 54 similar cases where RDVT's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:
RDVT in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 03, 2026
RDVT broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 30 of the 40 cases the stock fell afterwards. This puts the odds of success at 75%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 61 cases where RDVT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for RDVT turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 39 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 28, 2026. You may want to consider a long position or call options on RDVT as a result. In 68 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
Following a +5.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDVT advanced for three days, in 217 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 195 of 243 cases where RDVT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 24 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. RDVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.764) is normal, around the industry mean (28.425). P/E Ratio (65.658) is within average values for comparable stocks, (75.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.599). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (10.846) is also within normal values, averaging (78.066).